StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3077% above fair value
$266.17−4.39 (-1.62%)

Close on Nov 3, 2026Market cap $641.44BP/E 40.4Yield 1.93%

Johnson & Johnson Non-GAAP adjusted pre-tax profit margin by Quarter

Non-GAAP adjusted pre-tax profit margin (% to sales) (%)

QuarterlyAnnual

Johnson & Johnson Non-GAAP adjusted pre-tax profit margin: 30.2% in Q3 2026, down 5.0 pts from a year earlier.

Latest, Q3 2026
30.2%
Period ended Sep 30, 2026
Change on a year earlier
-5.0 pts
35.2% in Q3 2025
History
40 quarters
Since Q4 2016
Sources
36
Documents cited below

Where the Q3 2026 figure comes from

“|| Earnings before provision for taxes on income | $ | 7,672 | 30.2 | $ | 8,436 | 35.2 | (9.1)”

Source: Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗

Reported in Form 8-K EX-99.2 Condensed Consolidated Statement of Earnings.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP adjusted pre-tax profit margin (% to sales) (%)Year on yearSource
Q3 2026Sep 30, 202630.2%-5.0 ptsForm 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Q2 2026Jun 28, 202634.2%-0.3 ptsForm 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗
Q1 2026Mar 29, 202632.5%-4.1 ptsForm 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗
Q4 2025Dec 28, 202528.7%+4.6 ptsForm 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Q3 2025Sep 28, 202535.2%+2.8 ptsForm 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Q2 2025Jun 29, 202534.5%-2.9 ptsForm 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗
Q1 2025Mar 30, 202536.6%-0.2 ptsForm 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗
Q4 2024Dec 29, 202424.1%-5.1 ptsForm 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Q3 2024Sep 29, 202432.4%-5.2 ptsForm 8-K (a2025q3exhibit991.htm, filed 2025-10-14) ↗
Q2 2024Jun 30, 202437.4%+0.2 ptsForm 8-K (a2025q2exhibit991.htm, filed 2025-07-16) ↗
Q1 2024Mar 31, 202436.8%+0.7 ptsForm 8-K (a2025q1exhibit991.htm, filed 2025-04-15) ↗
Q4 2023Dec 31, 202329.2%-3.3 ptsForm 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗
Q3 2023Oct 1, 202337.6%+2.3 ptsForm 8-K (a2024q3exhibit991.htm, filed 2024-10-15) ↗
Q2 2023Jul 2, 202337.2%+3.2 ptsForm 8-K (a2024q2exhibit991.htm, filed 2024-07-17) ↗
Q1 2023Apr 2, 202336.1%+1.0 ptsForm 8-K (a2024q1exhibit991.htm, filed 2024-04-16) ↗
Q4 2022Jan 1, 202332.5%+6.9 ptsForm 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗

Cite this data

StockData. (2026). Johnson & Johnson Non-GAAP adjusted pre-tax profit margin (%), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/adj-pti-margin-pct

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.

See a number that looks wrong?